|
1
|
Rines AK, Sharabi K, Tavares CD and
Puigserver P: Targeting hepatic glucose metabolism in the treatment
of type 2 diabetes. Nat Rev Drug Discov. 15:786–804. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bugianesi E, McCullough AJ and Marchesini
G: Insulin resistance: A metabolic pathway to chronic liver
disease. Hepatology. 42:987–1000. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leclercq IA, Da Silva Morais A, Schroyen
B, Van Hul N and Geerts A: Insulin resistance in hepatocytes and
sinusoidal liver cells: Mechanisms and consequences. J Hepatol.
47:142–156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fernandez-Valverde SL, Taft RJ and Mattick
JS: MicroRNAs in beta-cell biology, insulin resistance, diabetes
and its complications. Diabetes. 60:1825–1831. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dou L, Zhao T, Wang L, Huang X, Jiao J,
Gao D, Zhang H, Shen T, Man Y, Wang S and Li J: miR-200s contribute
to interleukin-6 (IL-6)-induced insulin resistance in hepatocytes.
J Biol Chem. 288:22596–22606. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dou L, Wang S, Sui X, Meng X, Shen T,
Huang X, Guo J, Fang W, Man Y, Xi J and Li J: MiR-301a mediates the
effect of IL-6 on the AKT/GSK pathway and hepatic glycogenesis by
regulating PTEN expression. Cell Physiol Biochem. 35:1413–1424.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang S, Wang L, Dou L, Guo J, Fang W, Li
M, Meng X, Man Y, Shen T, Huang X and Li J: MicroRNA 152 regulates
hepatic glycogenesis by targeting PTEN. FEBS J. 283:1935–1946.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fang W, Guo J, Cao Y, Wang S, Pang C, Li
M, Dou L, Man Y, Huang X, Shen T and Li J: MicroRNA-20a-5p
contributes to hepatic glycogen synthesis through targeting p63 to
regulate p53 and PTEN expression. J Cell Mol Med. 20:1467–1480.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dou L, Meng X, Sui X, Wang S, Shen T,
Huang X, Guo J, Fang W, Man Y, Xi J and Li J: MiR-19a regulates
PTEN expression to mediate glycogen synthesis in hepatocytes. Sci
Rep. 5:116022015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen L, Li C, Zhang R, Gao X, Qu X, Zhao
M, Qiao C, Xu J and Li J: miR-17-92 cluster microRNAs confers
tumorigenicity in multiple myeloma. Cancer Lett. 309:62–70. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lanthier N and Leclercq IA: Liver and
systemic insulin resistance. Hepatology. 60:1113–1114. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Meshkani R and Adeli K: Hepatic insulin
resistance, metabolic syndrome and cardiovascular disease. Clin
Biochem. 42:1331–1346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Samue VT and Shulman GI: The pathogenesis
of insulin resistance: Integrating signaling pathways and substrate
flux. J Clin Invest. 126:12–22. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wan M, Leavens KF, Hunter RW, Koren S, von
Wilamowitz-Moellendorff A, Lu M, Satapati S, Chu Q, Sakamoto K,
Burgess SC and Birnbaum MJ: A noncanonical, GSK3-independent
pathway controls postprandial hepatic glycogen deposition. Cell
Metab. 18:99–105. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu M, Wan M, Leavens KF, Chu Q, Monks BR,
Fernandez S, Ahima RS, Ueki K, Kahn CR and Birnbaum MJ: Insulin
regulates liver metabolism in vivo in the absence of hepatic Akt
and Foxo1. Nat Med. 18:388–395. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoon JC, Puigserver P, Chen G, Donovan J,
Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, et al:
Control of hepatic gluconeogenesis through the transcriptional
coactivator PGC-1. Nature. 413:131–138. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Puigserver P, Rhee J, Donovan J, Walkey
CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D
and Spiegelman BM: Insulin-regulated hepatic gluconeogenesis
through FOXO1-PGC-1alpha interaction. Nature. 423:550–555. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gupta A and Dey CS: PTEN, a widely known
negative regulator of insulin/PI3K signaling, positively regulates
neuronal insulin resistance. Mol Biol Cell. 23:3882–3898. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Horie Y, Suzuki A, Kataoka E, Sasaki T,
Hamada K, Sasaki J, Mizuno K, Hasegawa G, Kishimoto H, Iizuka M, et
al: Hepatocyte-specific Pten deficiency results in steatohepatitis
and hepatocellular carcinomas. J Clin Invest. 113:1774–1783. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guenzl PM, Raim R, Kral J, Brunner J,
Sahin E and Schabbauer G: Insulin hypersensitivity induced by
hepatic PTEN gene ablation protects from murine endotoxemia. PLoS
One. 8:e670132013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Matsuda S, Kobayashi M and Kitagishi Y:
Roles for PI3K/AKT/PTEN pathway in cell signaling of nonalcoholic
fatty liver disease. ISRN endocrinol. 2013:4724322013. View Article : Google Scholar : PubMed/NCBI
|
